Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 7 pages · English
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- $3.5 Million R&D Tax Incentive Received
- Starpharma Investor Presentation Petalion Webinar
- Starpharma secures majority ownership of Petalion
- Trading Halt
- Change in substantial holding
Later from Starpharma
- Details of Company Address
- Application for quotation of securities - SPL
- Becoming a substantial holder
- AGM Chair address and CEO presentation
- Results of 2026 Annual General Meeting
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma